138 related articles for article (PubMed ID: 11484952)
21. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
[TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
[TBL] [Abstract][Full Text] [Related]
23. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer.
Popat S; Chen Z; Zhao D; Pan H; Hearle N; Chandler I; Shao Y; Aherne W; Houlston R
Ann Oncol; 2006 Dec; 17(12):1810-7. PubMed ID: 16971666
[TBL] [Abstract][Full Text] [Related]
24. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
[TBL] [Abstract][Full Text] [Related]
25. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A
Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
[TBL] [Abstract][Full Text] [Related]
26. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
27. Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer.
Broll R; Busch P; Duchrow M; Oevermann E; Schwandner O; Farke S; Bruch HP; Windhövel U
Int J Colorectal Dis; 2005 Mar; 20(2):94-102. PubMed ID: 15309465
[TBL] [Abstract][Full Text] [Related]
28. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
29. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma.
Gorlick R; Metzger R; Danenberg KD; Salonga D; Miles JS; Longo GS; Fu J; Banerjee D; Klimstra D; Jhanwar S; Danenberg PV; Kemeny N; Bertino JR
J Clin Oncol; 1998 Apr; 16(4):1465-9. PubMed ID: 9552053
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.
Bendardaf R; Lamlum H; Elzagheid A; Ristamäki R; Pyrhönen S
Oncol Rep; 2005 Sep; 14(3):657-62. PubMed ID: 16077970
[TBL] [Abstract][Full Text] [Related]
31. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
[TBL] [Abstract][Full Text] [Related]
32. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
[TBL] [Abstract][Full Text] [Related]
33. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.
Wong NA; Brett L; Stewart M; Leitch A; Longley DB; Dunlop MG; Johnston PG; Lessells AM; Jodrell DI
Br J Cancer; 2001 Dec; 85(12):1937-43. PubMed ID: 11747337
[TBL] [Abstract][Full Text] [Related]
34. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.
Saw RP; Koorey D; Painter D; Gallagher PJ; Solomon MJ
Br J Surg; 2002 Nov; 89(11):1409-15. PubMed ID: 12390383
[TBL] [Abstract][Full Text] [Related]
35. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
Jensen SA; Vainer B; Sørensen JB
Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
[TBL] [Abstract][Full Text] [Related]
38. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine.
Davies MM; Johnston PG; Kaur S; Allen-Mersh TG
Clin Cancer Res; 1999 Feb; 5(2):325-8. PubMed ID: 10037181
[TBL] [Abstract][Full Text] [Related]
39. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival.
Nitti D; Belluco C; Montesco MC; Bertorelle R; Da Pian PP; Fassina A; Ninfo V; Chieco-Bianchi L; Lise M
Eur J Cancer; 1998 May; 34(6):851-5. PubMed ID: 9797697
[TBL] [Abstract][Full Text] [Related]
40. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
